Health Care

The company reported higher-than-expected quarterly earnings due to favorable taxes and cost controls, but sales missed expectations.

The blue-chip insurer posted quarterly profits that topped expectations, but sales missed estimates and the company sharply lowered its outlook. 

The world's largest household products company is reportedly seeking to pay its bills in 75 days from the average of 45 days it takes currently.

The health care company earnings from continuing operations were roughly in line with forecasts, rising on demand for its nutritional and diagnostic products.

The medical technology company reported first-quarter net earnings were $222 million compared with $212 million the year prior.

China's Ministry of Commerce conditionally backed the $35 billion deal, the largest merger in mining history.

The pharmaceutical company plans reduce its U.S. sales group by nearly 1,000 representatives as part of a major restructuring, according to a report Thursday by Dow Jones Newswires.

The nominee to lead the healthcare agency said it was investigating events surrounding a decision on Medicare Advantage payment rates that sent shares of insurance companies soaring.

Rite Aid unexpectedly swung to a profit in the 2Q, as it continued to log higher sales while generic drugs boosted margins.

The private equity titan will likely gain preferential negotiating rights in talks to buy a majority stake in Panasonic’s healthcare unit, a deal potentially worth $1.5 billion.

With concerns over healthcare costs and access top of mind for most, consumers should be aware of changes to the Affordable Care Act going into effect this year. The deadline for open enrollment is Jan. 31.

If you've paid into Social Security, you may qualify for Medicare even after living abroad.

As many of 35,000 Californians who think they have signed up for health insurance through the state’s exchange might be in for a rude awakening in January.

Merck will buy Cubist Pharmaceuticals in a $9.5 billion deal, giving the major drugmaker an entry into the market for drugs that target so-called superbugs.

Johnson & Johnson CEO Alex Gorsky joined FBN’s Maria Bartiromo to discuss the company’s second-quarter earnings.

U.S. health-care companies are stepping up efforts to merge with rivals from overseas, seeking to benefit from lower tax rates in countries like the UK.

Walgreen's same-store sales climbed 7.5% in June, citing strength in the pharmacy segment.

More Americans are smoking and eating marijuana as negative perceptions about the plant continue to fade, according to a United Nations report. 

Walgreen's third-quarter earnings rose 15.7% amid stronger sales of prescription drugs.

Allergan once again rejected Valeant's efforts to acquire the Botox maker, telling its shareholders to turn down an unsolicited tender offer.